(Albany, US) DelveInsight launched its new report on Vasomotor symptoms (Hot flashes/Night sweats)–Market Insights, Epidemiology and Market Forecast—2030
DelveInsight’s ‘Vasomotor symptoms (Hot flashes/Night sweats)–Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the Vasomotor symptoms including Hot flashes or night sweats, historical and forecasted epidemiology as well as the Vasomotor symptoms (Hot flashes/Night sweats) market trends in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
Some of the key facts of the report:The United States has recorded the highest prevalent population of Hot Flashes associated with Post Menopause of 18,926,632 cases in 2017.
Key benefits of the report:1. Vasomotor Symptoms market report covers a descriptive overview and comprehensive insight of the Vasomotor Symptoms epidemiology and Vasomotor Symptoms market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)2. Vasomotor Symptoms market report provides insights into the current and emerging therapies.3. Vasomotor Symptoms market report provides a global historical and forecasted market covering drug outreach in 7 MM.4. Vasomotor Symptoms market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Vasomotor Symptoms market.
“The total prevalent population of Vasomotor Symptoms associated with post menopause in 7MM countries was 41,096,968 in 2017.”
“Hot Flashes refer to the sudden sensation of extreme heat in the upper body, particularly the face, neck, and chest. The current therapeutic landscape of Hot Flashes Associated with menopause in the US can be divided into two major categories based on the class of drug. These are Hormonal Therapies and Nonhormonal Therapy.”
The key players in Vasomotor Symptoms market are:1. Mithra Pharmaceuticals (Donesta Biosciences)2. KaNDy Therapeutics3. Fervent Pharmaceuticals4. Astellas Pharma5. Sojournix6. Mitsubishi Tanabe Pharma
The launch of the emerging therapies is expected to significantly impact Vasomotor Symptoms treatment scenario in the upcoming years:-
Drugs covered1. Donesta2. NT-8143. FP-1014. Fezolinetant5. SJX 6536. MT-8554
Table of contents1. Key Insights2. Vasomotor Symptoms Market Overview at a Glance3. Executive summary4. Organizations5. Vasomotor Symptoms Epidemiology and Market Methodology6. Vasomotor Symptoms associated with menopause Disease Background and Overview7. Vasomotor Symptoms Epidemiology and Patient Population8. Total Vasomotor Symptoms in Post-menopause Prevalent cases in 7MM9. Country Wise Hot Flashes Associated with Post-menopause Epidemiology9.1. United States9.2. EU5 Countries9.3. Germany9.4. France9.5. Italy9.6. Spain9.7. United Kingdom9.8. Japan10. Vasomotor Symptoms Treatment Algorithm, Current Treatment, and Medical Practices11. Unmet Needs12. Vasomotor Symptoms Marketed drugs by class12.1. Hormonal Therapies12.2. Non-hormonal Therapies12.3. Recent additions in Hormonal therapies12.4. Bijuva: TherapeuticsMD13. Vasomotor Symptoms Emerging Therapies13.1. Key Cross Competition13.2. Hormonal Based therapies13.3. Donesta: Mithra Pharmaceuticals (Donesta Biosciences)13.4. Non-Hormonal Based therapies13.5. NT-814: KaNDy Therapeutics13.6. FP-101: Fervent Pharmaceuticals13.7. Fezolinetant: Astellas Pharma13.8. Other Potential therapies13.9. SJX 653: Sojournix13.10. MT-8554: Mitsubishi Tanabe Pharma14. Hot Flashes 7 Major Market Analysis15. Seven Major Market Outlook15.1. United States Market Size15.2. Germany15.3. France15.4. Italy15.5. Spain15.6. United Kingdom15.7. Japan16. Market Drivers17. Market Barriers18. SWOT19. Case Studies20. KOL Views21. Appendix22. DelveInsight Capabilities23. Disclaimer24. About DelveInsight
Related reports:
Vasomotor symptoms (Hot flashes/Night sweats)– Epidemiology Forecast—2030
Vasomotor Symptoms of Menopause Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Anuj RawatEmail: Send EmailPhone: +919650213330Address:304 S. Jones Blvd #2432 City: AlbanyState: New YorkCountry: United StatesWebsite: https://www.delveinsight.com/